BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15194433)

  • 1. FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells.
    Krejci P; Bryja V; Pachernik J; Hampl A; Pogue R; Mekikian P; Wilcox WR
    Exp Cell Res; 2004 Jul; 297(1):152-64. PubMed ID: 15194433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis.
    Krejci P; Masri B; Fontaine V; Mekikian PB; Weis M; Prats H; Wilcox WR
    J Cell Sci; 2005 Nov; 118(Pt 21):5089-100. PubMed ID: 16234329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2.
    Aikawa T; Segre GV; Lee K
    J Biol Chem; 2001 Aug; 276(31):29347-52. PubMed ID: 11384971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of fibroblast growth factor receptor 3 by fibroblast growth factor 2 in cultured chick embryo chondrocytes.
    Suh JY; Kim YS; Park JW; Sonn JK; Kim WT
    Cell Biol Int; 2005 Mar; 29(3):203-12. PubMed ID: 15878293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of Akt activity contributes to the growth arrest induced by FGF in chondrocytes.
    Priore R; Dailey L; Basilico C
    J Cell Physiol; 2006 Jun; 207(3):800-8. PubMed ID: 16523491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
    Touyz RM; Yao G
    J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic expression of Cdk6 circumvents transforming growth factor-beta mediated growth inhibition.
    Zhang F; Taipale M; Heiskanen A; Laiho M
    Oncogene; 2001 Sep; 20(41):5888-96. PubMed ID: 11593394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes.
    Krejci P; Salazar L; Goodridge HS; Kashiwada TA; Schibler MJ; Jelinkova P; Thompson LM; Wilcox WR
    J Cell Sci; 2008 Feb; 121(Pt 3):272-81. PubMed ID: 18198189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells.
    Zi X; Grasso AW; Kung HJ; Agarwal R
    Cancer Res; 1998 May; 58(9):1920-9. PubMed ID: 9581834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation.
    Dailey L; Laplantine E; Priore R; Basilico C
    J Cell Biol; 2003 Jun; 161(6):1053-66. PubMed ID: 12821644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK.
    Koike M; Yamanaka Y; Inoue M; Tanaka H; Nishimura R; Seino Y
    J Bone Miner Res; 2003 Nov; 18(11):2043-51. PubMed ID: 14606518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and activity of the CDK inhibitor p57Kip2 in chondrocytes undergoing hypertrophic differentiation.
    Stewart MC; Kadlcek RM; Robbins PD; MacLeod JN; Ballock RT
    J Bone Miner Res; 2004 Jan; 19(1):123-32. PubMed ID: 14753744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor and canonical WNT/β-catenin signaling cooperate in suppression of chondrocyte differentiation in experimental models of FGFR signaling in cartilage.
    Buchtova M; Oralova V; Aklian A; Masek J; Vesela I; Ouyang Z; Obadalova T; Konecna Z; Spoustova T; Pospisilova T; Matula P; Varecha M; Balek L; Gudernova I; Jelinkova I; Duran I; Cervenkova I; Murakami S; Kozubik A; Dvorak P; Bryja V; Krejci P
    Biochim Biophys Acta; 2015 May; 1852(5):839-50. PubMed ID: 25558817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGFR3 isoforms have distinct functions in the regulation of growth and cell morphology.
    Shimizu A; Takashima Y; Kurokawa-Seo M
    Biochem Biophys Res Commun; 2002 Jan; 290(1):113-20. PubMed ID: 11779141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Cdk6 expression through p38 MAP kinase is involved in differentiation of mouse prechondrocyte ATDC5.
    Moro T; Ogasawara T; Chikuda H; Ikeda T; Ogata N; Maruyama Z; Komori T; Hoshi K; Chung UI; Nakamura K; Okayama H; Kawaguchi H
    J Cell Physiol; 2005 Sep; 204(3):927-33. PubMed ID: 15795936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTHrP rescues ATDC5 cells from apoptosis induced by FGF receptor 3 mutation.
    Yamanaka Y; Tanaka H; Koike M; Nishimura R; Seino Y
    J Bone Miner Res; 2003 Aug; 18(8):1395-403. PubMed ID: 12929929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model.
    Jonquoy A; Mugniery E; Benoist-Lasselin C; Kaci N; Le Corre L; Barbault F; Girard AL; Le Merrer Y; Busca P; Schibler L; Munnich A; Legeai-Mallet L
    Hum Mol Genet; 2012 Feb; 21(4):841-51. PubMed ID: 22072392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligands expressed in human fetal growth plate cartilage.
    Krejci P; Krakow D; Mekikian PB; Wilcox WR
    Pediatr Res; 2007 Mar; 61(3):267-72. PubMed ID: 17314681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway.
    Sahni M; Ambrosetti DC; Mansukhani A; Gertner R; Levy D; Basilico C
    Genes Dev; 1999 Jun; 13(11):1361-6. PubMed ID: 10364154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.
    Yasoda A; Komatsu Y; Chusho H; Miyazawa T; Ozasa A; Miura M; Kurihara T; Rogi T; Tanaka S; Suda M; Tamura N; Ogawa Y; Nakao K
    Nat Med; 2004 Jan; 10(1):80-6. PubMed ID: 14702637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.